Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 14  •  04:00PM ET
33.66
Dollar change
+0.34
Percentage change
1.01
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y22.04% Total Holdings36 Perf Week6.57%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM79.85M Perf Month9.32%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter23.45%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High35.01 -3.83% Perf Half Y47.65%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 79.25% Perf YTD43.92%
Active/Passive Quant Type Tagsmedical Flows% 1M1.25% Volatility1.70% 1.18% Perf Year-
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M3.62% ATR (14)0.72 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD11.57% RSI (14)62.38 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.41 Perf 10Y-
Expense0.54% Growth/Value SMA204.62% Flows% 3Y Rel Volume0.34 Prev Close33.33
Inverse/Leveraged Market Cap SMA5010.31% Flows% 5Y Avg Volume2.92K Price33.66
IPOOct 31, 2024 Option/ShortNo / Yes SMA20030.56% Trades Volume993 Change1.01%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.